Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.042 SGD | +2.44% | +5.00% | -6.67% |
Mar. 12 | Singaporean Shares End Marginally Higher; Biopharma's Shares Climb 2% on Introduction of New Sublingual Wafer | MT |
Mar. 12 | IX Biopharma Introduces New Sublingual Wafer | MT |
Sales 2022 | 14.39M 10.58M | Sales 2023 | 5.91M 4.35M | Capitalization | 69.73M 51.26M |
---|---|---|---|---|---|
Net income 2022 | -4M -2.94M | Net income 2023 | -9M -6.62M | EV / Sales 2022 | 7.87 x |
Net cash position 2022 | 9.18M 6.75M | Net cash position 2023 | 2.2M 1.61M | EV / Sales 2023 | 11.4 x |
P/E ratio 2022 |
-26.3
x | P/E ratio 2023 |
-7.22
x | Employees | 45 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 49.01% |
1 day | +2.44% | ||
1 week | +5.00% | ||
Current month | -19.23% | ||
1 month | -19.23% | ||
3 months | -2.33% | ||
Current year | -6.67% |
Managers | Title | Age | Since |
---|---|---|---|
Yip Hang Lee
CEO | Chief Executive Officer | - | 04-05-07 |
Sien Lup Chew
DFI | Director of Finance/CFO | 60 | 16-04-13 |
Chief Operating Officer | 45 | 16-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Yip Hang Lee
CEO | Chief Executive Officer | - | 04-05-07 |
Shing Tung Ho
BRD | Director/Board Member | 57 | 13-02-28 |
Patrick Davies
BRD | Director/Board Member | 57 | 19-12-01 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 0.042 | +2.44% | 10 000 |
24-04-25 | 0.041 | -4.65% | 179,900 |
24-04-22 | 0.043 | +7.50% | 196,900 |
24-04-19 | 0.04 | -11.11% | 189,600 |
24-04-18 | 0.045 | -6.25% | 128,800 |
Delayed Quote Singapore S.E., April 26, 2024 at 02:31 am EDT
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-6.67% | 23.16M | |
+24.17% | 556B | |
-6.33% | 354B | |
+19.90% | 331B | |
+7.95% | 296B | |
+13.45% | 233B | |
+6.04% | 201B | |
-10.51% | 193B | |
-12.26% | 143B | |
-6.47% | 144B |
- Stock Market
- Equities
- 42C Stock